関連する実験動画
Updated: Aug 7, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
まとめ
ベクロメタゾーン二プロピオネートエアロゾールは,慢性気管性喘息患者の経口コルチコステロイドの使用を減らすのに役立ちました. これにより,腎上腺機能が改善され,ステロイドの副作用が少なくなり,耐性は良好でした.
科学分野:
- 肺内科 肺内科 肺内科
- アレルギーと免疫学
- 薬理学 薬理学とは
背景:
- 慢性気管支柱性喘息は,しばしば長期の経口コルチコステロイド療法を必要とします.
- 口服用コルチコステロイドは,有意な全身的副作用と腎上腺抑制と関連しています.
- 喘息を管理し,コルチコステロイド依存を減らすために,代替的な治療戦略が必要である.
研究 の 目的:
- 慢性気管性喘息の患者における経口用コルチコステロイドの必要性を減らすためのベクロメタゾン二プロピオネートエアロゾールの有効性を評価する.
- ベクロメタゾンエアロゾール療法が腎上腺機能とステロイド関連の毒性反応に与える影響を評価する.
主な方法:
- ランダム化され,プラセボ対照試験で,経口コルチコステロイド療法を必要とする慢性支柱性喘息の30人の患者が参加しました.
- 患者は12週間にわたってベクロメタゾン二プロピオネートエアロゾールまたは惰性エアロゾールプラセボを投与された.
- 後にベクロメタゾンへのクロスオーバーは,プラセボを受けた患者に対して,6ヶ月の観察期間で許可された.
主要な成果:
- ベクロメタゾンのエアロゾルは,プラセボを受けた14人中1人の患者と比べて,16人中12人の患者で12週間以内に経口コルチコステロイドの中止を可能にしました.
- 経口用コルチコステロイドの投与を中止した患者では,腎上腺機能が改善され,ステロイドの毒性反応は6ヶ月間にわたって減少しました.
- ベクロメタゾンのエアロゾールは一般的によく耐えられ,一部の患者では無症状のトースチや鼻炎が報告されました.
結論:
- ベクロメタゾーン二プロピオネートエアロゾールは,慢性支柱性喘息の効果的な補助療法であり,経口コルチコステロイドの必要性を大幅に軽減します.
- ベクロメタゾンエアロゾールへの切り替えは,腎上腺機能の改善と,長期の経口ステロイド使用に関連した副作用の減少につながる可能性があります.
- ベクロメタゾンのエアロゾールは,慢性喘息の管理とコルチコステロイド誘発の合併症の軽減に有利な安全性プロファイルを提供します.
関連する概念動画
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...